Sensars, a pioneering medtech company, has stepped up to fill in this gap with its groundbreaking approach to neuromodulation ...

A recent study from Osaka University reveals that intensive diabetes treatment can improve periodontal disease inflammation.

A blister (vesicle) is a small pocket of fluid that forms beneath the skin as a result of an injury, but also allergic ...

These ulcers, affecting approximately 15% of diabetic patients, stem from underlying conditions including peripheral neuropathy, peripheral artery ... including applying topical antibacterials to aid ...

For patients with advanced melanoma, these long-term follow-up data showed the 10-year OS rate for KEYTRUDA was 34.0% versus 23.6% for ipilimumab. KEYTRUDA demonstrated a sustained OS benefit, ...

MIAMI, FL / ACCESSWIRE / September 11, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a preclinical-stage pharmaceutical company focused on ...

KEYTRUDA, in combination with chemotherapy, with or without bevacizumab, is indicated for the treatment of patients with persistent, recurrent, or metastatic cervical cancer whose tumors express PD-L1 ...

Detailed results from the TROPION-Lung01 Phase III trial showed a clinically meaningful trend toward improving overall survival (OS) with datopotamab ...